These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 24503189)

  • 1. A novel heterozygous mutation in the glucokinase gene conferring exercise-induced symptomatic hyperglycaemia responsive to sulfonylurea.
    Ebrahim MS; Lawson ML; Geraghty MT
    Diabetes Metab; 2014 Sep; 40(4):310-3. PubMed ID: 24503189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2.
    Loomba-Albrecht LA; Jame M; Bremer AA
    Diabetes Res Clin Pract; 2010 Mar; 87(3):e23-5. PubMed ID: 20015564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term impact on offspring of exposure to hyperglycaemia in utero due to maternal glucokinase gene mutations.
    Singh R; Pearson ER; Clark PM; Hattersley AT
    Diabetologia; 2007 Mar; 50(3):620-4. PubMed ID: 17216282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent neonatal diabetes caused by a homozygous nonsense mutation in the glucokinase gene.
    Rubio-Cabezas O; Díaz González F; Aragonés A; Argente J; Campos-Barros A
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):245-9. PubMed ID: 18298419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced oxidative stress and endocrine pancreas alterations are linked to a novel glucokinase missense mutation in ENU-derived Munich Gck(D217V) mutants.
    van Buerck L; Schuster M; Rathkolb B; Sabrautzki S; Hrabě de Angelis M; Wolf E; Aigner B; Wanke R; Herbach N
    Mol Cell Endocrinol; 2012 Oct; 362(1-2):139-48. PubMed ID: 22698525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
    Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
    Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MODY2 caused by a novel mutation of GCK gene.
    Pulst K; Arbo T; Kahre T; Peet A; Tillmann V
    J Pediatr Endocrinol Metab; 2012; 25(7-8):801-3. PubMed ID: 23155715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis.
    Davis EA; Cuesta-Muñoz A; Raoul M; Buettger C; Sweet I; Moates M; Magnuson MA; Matschinsky FM
    Diabetologia; 1999 Oct; 42(10):1175-86. PubMed ID: 10525657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fasting hyperglycaemia and polymorphism in glucokinase promoter (rs1799884)].
    Bahíllo Curieses P; Hermoso López F; Garrote Molpeceres R; Zurita Muñoz O; Campos Barros A
    An Pediatr (Barc); 2011 Oct; 75(4):273-6. PubMed ID: 21697023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucokinase mutations in young children with hyperglycemia.
    Codner E; Deng L; Pérez-Bravo F; Román R; Lanzano P; Cassorla F; Chung WK
    Diabetes Metab Res Rev; 2006; 22(5):348-55. PubMed ID: 16444761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of mutation carriers in a large family with glucokinase diabetes (MODY2).
    Shehadeh N; Bakri D; Njølstad PR; Gershoni-Baruch R
    Diabet Med; 2005 Aug; 22(8):994-8. PubMed ID: 16026363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families.
    Velho G; Blanché H; Vaxillaire M; Bellanné-Chantelot C; Pardini VC; Timsit J; Passa P; Deschamps I; Robert JJ; Weber IT; Marotta D; Pilkis SJ; Lipkind GM; Bell GI; Froguel P
    Diabetologia; 1997 Feb; 40(2):217-24. PubMed ID: 9049484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
    Froguel P; Zouali H; Vionnet N; Velho G; Vaxillaire M; Sun F; Lesage S; Stoffel M; Takeda J; Passa P
    N Engl J Med; 1993 Mar; 328(10):697-702. PubMed ID: 8433729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation.
    Sagen JV; Odili S; Bjørkhaug L; Zelent D; Buettger C; Kwagh J; Stanley C; Dahl-Jørgensen K; de Beaufort C; Bell GI; Han Y; Grimsby J; Taub R; Molven A; Søvik O; Njølstad PR; Matschinsky FM
    Diabetes; 2006 Jun; 55(6):1713-22. PubMed ID: 16731834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose modulation of ATP-sensitive K-currents in wild-type, homozygous and heterozygous glucokinase knock-out mice.
    Sakura H; Ashcroft SJ; Terauchi Y; Kadowaki T; Ashcroft FM
    Diabetologia; 1998 Jun; 41(6):654-9. PubMed ID: 9662046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small-molecule glucokinase activator lowers blood glucose in the sulfonylurea-desensitized rat.
    Ohyama S; Takano H; Iino T; Nishimura T; Zhou YP; Langdon RB; Zhang BB; Eiki J
    Eur J Pharmacol; 2010 Aug; 640(1-3):250-6. PubMed ID: 20465996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
    Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
    Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
    Turkkahraman D; Bircan I; Tribble ND; Akçurin S; Ellard S; Gloyn AL
    J Pediatr; 2008 Jul; 153(1):122-6. PubMed ID: 18571549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
    Guerci B; Monnier L; Serusclat P; Petit C; Valensi P; Huet D; Raccah D; Colette C; Quéré S; Dejager S
    Diabetes Metab; 2012 Oct; 38(4):359-66. PubMed ID: 22809630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabbit lens and retina phosphorylate glucose through a glucokinase-like enzyme: study in normal and spontaneously hyperglycemic animals.
    Iannello S; Campione R; Volpicelli G; Belfiore F
    J Diabetes Complications; 1996; 10(2):68-77. PubMed ID: 8777333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.